Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Clinical trial NCT00766116 · COMPLETED
Trial details
- NCT number
- NCT00766116
- Sponsor
- University of California, San Diego
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2014-09-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.